{"hands_on_practices": [{"introduction": "Group sequential designs depend on the fact that test statistics from interim analyses are correlated. This exercise [@problem_id:4918094] is fundamental, as it asks you to derive the covariance matrix that captures this relationship from the underlying theory of Brownian motion. Mastering this concept is key to understanding how stopping boundaries are calculated and how the overall error rate is controlled across multiple looks.", "problem": "A two-arm randomized clinical trial is monitored using a group sequential design with three analyses at information times $t_{1} = 0.25$, $t_{2} = 0.50$, and $t_{3} = 1.00$. Under the canonical joint normal framework, the sequential test statistics $\\{Z_{i}\\}$ are modeled via a standardized Brownian motion with drift representation: for each analysis time $t$, the statistic $Z(t)$ is defined by $Z(t) = \\left(W(t) + \\theta t\\right)/\\sqrt{t}$, where $W(t)$ is standard Brownian motion and $\\theta$ is a constant drift parameter representing the standardized treatment effect. It is known that $W(t)$ has covariance function $\\operatorname{Cov}\\!\\left(W(s), W(t)\\right) = \\min\\{s,t\\}$ and $W(0) = 0$.\n\nStarting from these fundamental definitions, derive the covariance matrix of $\\left(Z_{1}, Z_{2}, Z_{3}\\right)$ at $\\left(t_{1}, t_{2}, t_{3}\\right)$ and express its entries in exact closed form. Then verify that this covariance matrix is positive semidefinite by reasoning from first principles. Express the matrix entries in simplest exact form using radicals and fractions, and do not round any quantities.", "solution": "The problem specifies a canonical joint normal representation of interim test statistics in a group sequential design. The foundational base is the standardized Brownian motion with drift $W(t)$, which is a Gaussian process with $W(0) = 0$, mean $0$, and covariance function $\\operatorname{Cov}\\!\\left(W(s), W(t)\\right) = \\min\\{s,t\\}$. The canonical statistic at time $t$ is given by\n$$\nZ(t) = \\frac{W(t) + \\theta t}{\\sqrt{t}}.\n$$\nFor any fixed set of analysis times $t_{1}, t_{2}, t_{3}$, the vector $\\left(Z(t_{1}), Z(t_{2}), Z(t_{3})\\right)$ is jointly normal. Its covariance structure can be derived directly from the covariance of $W(t)$, as the drift $\\theta t$ contributes only to the mean and not to the covariance.\n\nSpecifically, for $i,j \\in \\{1,2,3\\}$,\n$$\n\\operatorname{Cov}\\!\\left(Z(t_{i}), Z(t_{j})\\right)\n= \\operatorname{Cov}\\!\\left(\\frac{W(t_{i})}{\\sqrt{t_{i}}}, \\frac{W(t_{j})}{\\sqrt{t_{j}}}\\right)\n= \\frac{\\operatorname{Cov}\\!\\left(W(t_{i}), W(t_{j})\\right)}{\\sqrt{t_{i} t_{j}}}\n= \\frac{\\min\\{t_{i}, t_{j}\\}}{\\sqrt{t_{i} t_{j}}}.\n$$\nThis shows that the covariance matrix $\\Sigma$ has entries\n$$\n\\Sigma_{ij} = \\frac{\\min\\{t_{i}, t_{j}\\}}{\\sqrt{t_{i} t_{j}}}.\n$$\nObserve that for $i = j$, $\\Sigma_{ii} = \\min\\{t_{i}, t_{i}\\}/t_{i} = 1$, so each $Z(t_{i})$ is standardized to variance $1$. For $i  j$, $\\Sigma_{ij} = \\frac{t_{i}}{\\sqrt{t_{i} t_{j}}} = \\sqrt{\\frac{t_{i}}{t_{j}}}$.\n\nWith $t_{1} = 0.25$, $t_{2} = 0.50$, $t_{3} = 1.00$, we compute the off-diagonal entries:\n- For $i=1$, $j=2$, $\\Sigma_{12} = \\sqrt{\\frac{t_{1}}{t_{2}}} = \\sqrt{\\frac{0.25}{0.50}} = \\sqrt{\\frac{1}{2}} = \\frac{1}{\\sqrt{2}}$.\n- For $i=1$, $j=3$, $\\Sigma_{13} = \\sqrt{\\frac{t_{1}}{t_{3}}} = \\sqrt{\\frac{0.25}{1.00}} = \\sqrt{\\frac{1}{4}} = \\frac{1}{2}$.\n- For $i=2$, $j=3$, $\\Sigma_{23} = \\sqrt{\\frac{t_{2}}{t_{3}}} = \\sqrt{\\frac{0.50}{1.00}} = \\sqrt{\\frac{1}{2}} = \\frac{1}{\\sqrt{2}}$.\n\nBy symmetry, $\\Sigma_{21} = \\Sigma_{12}$, $\\Sigma_{31} = \\Sigma_{13}$, and $\\Sigma_{32} = \\Sigma_{23}$. The full covariance matrix is\n$$\n\\Sigma =\n\\begin{pmatrix}\n1  \\frac{1}{\\sqrt{2}}  \\frac{1}{2} \\\\\n\\frac{1}{\\sqrt{2}}  1  \\frac{1}{\\sqrt{2}} \\\\\n\\frac{1}{2}  \\frac{1}{\\sqrt{2}}  1\n\\end{pmatrix}.\n$$\n\nWe now verify that $\\Sigma$ is positive semidefinite. A conceptually grounded approach is to use the fact that $\\Sigma$ arises from a covariance of a jointly normal vector constructed from $W(t)$ via linear scaling. Any covariance matrix of a Gaussian vector is symmetric and positive semidefinite by construction. Nevertheless, we can verify positive semidefiniteness explicitly by showing that all eigenvalues of $\\Sigma$ are nonnegative.\n\nBecause $\\Sigma$ is symmetric with a palindromic structure across the first and third coordinates, we can exploit symmetry to find eigenvalues. Let $a = \\frac{1}{\\sqrt{2}}$ and $b = \\frac{1}{2}$. Consider the eigenvector $v_{1} = \\begin{pmatrix} 1 \\\\ 0 \\\\ -1 \\end{pmatrix}$. Then\n$$\n\\Sigma v_{1} =\n\\begin{pmatrix}\n1  a  b \\\\\na  1  a \\\\\nb  a  1\n\\end{pmatrix}\n\\begin{pmatrix} 1 \\\\ 0 \\\\ -1 \\end{pmatrix}\n=\n\\begin{pmatrix}\n1 - b \\\\ a - a \\\\ b - 1\n\\end{pmatrix}\n=\n\\begin{pmatrix}\n\\frac{1}{2} \\\\ 0 \\\\ -\\frac{1}{2}\n\\end{pmatrix}\n=\n\\frac{1}{2}\n\\begin{pmatrix}\n1 \\\\ 0 \\\\ -1\n\\end{pmatrix}.\n$$\nTherefore, $v_{1}$ is an eigenvector with eigenvalue $\\lambda_{1} = \\frac{1}{2}$.\n\nNext, consider eigenvectors of the form $v = \\begin{pmatrix} 1 \\\\ r \\\\ 1 \\end{pmatrix}$, which exploit the symmetry between the first and third coordinates. Compute\n$$\n\\Sigma v =\n\\begin{pmatrix}\n1 + a r + b \\\\\na + r + a \\\\\n1 + a r + b\n\\end{pmatrix}\n=\n\\begin{pmatrix}\n1 + a r + b \\\\\nr + 2 a \\\\\n1 + a r + b\n\\end{pmatrix}.\n$$\nIf $v$ is an eigenvector with eigenvalue $\\lambda$, then we must have\n$$\n1 + a r + b = \\lambda, \\quad r + 2 a = \\lambda r.\n$$\nEliminating $\\lambda$ using $\\lambda = 1 + a r + b$ yields the quadratic equation in $r$:\n$$\n(1 + a r + b) r = r + 2 a\n\\;\\;\\Longrightarrow\\;\\;\na r^{2} + b r = 2 a.\n$$\nWith $a = \\frac{1}{\\sqrt{2}}$ and $b = \\frac{1}{2}$, this becomes\n$$\n\\frac{1}{\\sqrt{2}} r^{2} + \\frac{1}{2} r - \\frac{2}{\\sqrt{2}} = 0.\n$$\nMultiplying through by $\\sqrt{2}$ gives\n$$\nr^{2} + \\frac{1}{\\sqrt{2}} r - 2 = 0,\n$$\nwhose solutions are\n$$\nr = \\frac{-\\frac{1}{\\sqrt{2}} \\pm \\sqrt{\\left(\\frac{1}{\\sqrt{2}}\\right)^{2} + 8}}{2}\n= \\frac{-\\frac{1}{\\sqrt{2}} \\pm \\sqrt{\\frac{1}{2} + 8}}{2}\n= \\frac{-\\frac{1}{\\sqrt{2}} \\pm \\sqrt{\\frac{17}{2}}}{2}\n= \\frac{-1 \\pm \\sqrt{17}}{2 \\sqrt{2}}.\n$$\nFor each root $r$, the corresponding eigenvalue is\n$$\n\\lambda = 1 + a r + b = \\frac{3}{2} + \\frac{r}{\\sqrt{2}}.\n$$\nSince $\\frac{r}{\\sqrt{2}} = \\frac{-1 \\pm \\sqrt{17}}{4}$, the two eigenvalues are\n$$\n\\lambda_{2} = \\frac{5}{4} + \\frac{\\sqrt{17}}{4}, \\qquad \\lambda_{3} = \\frac{5}{4} - \\frac{\\sqrt{17}}{4}.\n$$\nNumerically, $\\lambda_{1} = \\frac{1}{2}  0$, $\\lambda_{2} = \\frac{5 + \\sqrt{17}}{4} \\approx 2.2808  0$, and $\\lambda_{3} = \\frac{5 - \\sqrt{17}}{4} \\approx 0.2192  0$. All three eigenvalues are strictly positive, hence $\\Sigma$ is positive definite (and therefore positive semidefinite). This verifies the desired property from first principles.\n\nTherefore, the covariance matrix is\n$$\n\\Sigma =\n\\begin{pmatrix}\n1  \\frac{1}{\\sqrt{2}}  \\frac{1}{2} \\\\\n\\frac{1}{\\sqrt{2}}  1  \\frac{1}{\\sqrt{2}} \\\\\n\\frac{1}{2}  \\frac{1}{\\sqrt{2}}  1\n\\end{pmatrix},\n$$\nwhich is positive semidefinite by virtue of its eigenvalues being nonnegative.", "answer": "$$\\boxed{\\begin{pmatrix}\n1  \\frac{1}{\\sqrt{2}}  \\frac{1}{2} \\\\\n\\frac{1}{\\sqrt{2}}  1  \\frac{1}{\\sqrt{2}} \\\\\n\\frac{1}{2}  \\frac{1}{\\sqrt{2}}  1\n\\end{pmatrix}}$$", "id": "4918094"}, {"introduction": "A well-designed clinical trial has predictable operating characteristics. This practice problem [@problem_id:4918101] gives you the chance to calculate the probabilities of stopping a trial early, for either success or futility, under a specific assumption about the treatment's true effect. This skill is vital for evaluating whether a proposed set of stopping rules is ethically and practically sound before a trial even begins.", "problem": "A two-arm randomized superiority trial compares a continuous clinical outcome between an experimental group and a control group, with known and common standard deviation $\\sigma$. The design includes one planned interim analysis at information fraction $t = 0.5$ (half the total information), followed by a final analysis if the interim boundaries are not crossed. At each analysis, the monitoring statistic is the standardized $z$-statistic $Z(t)$ formed by dividing the estimated mean difference by its standard error, so that, under a fixed alternative, the canonical joint normal model implies $Z(t) \\sim \\mathcal{N}(\\mu \\sqrt{t}, 1)$, where $\\mu$ is the standardized effect size (the drift parameter induced by the true mean difference).\n\nInterim monitoring uses two non-overlapping stopping rules at the interim look:\n- Early efficacy: stop if $Z(t) \\geq a_{1}$.\n- Early futility: stop if $Z(t) \\leq b_{1}$.\n\nIf neither boundary is crossed at the interim, the trial continues to the final analysis. Consider a one-sided monitoring design with interim boundaries $a_{1} = 2.342$ (efficacy) and $b_{1} = 0.2$ (futility), and suppose the true standardized effect size is $\\mu = 1.5$.\n\nUsing only the properties of the normal distribution and the definition of $Z(t)$ under the canonical joint normal model, compute the joint probability vector of early stopping at the interim for efficacy versus futility under $\\mu$, that is $\\left(P_{\\text{efficacy}}, P_{\\text{futility}}\\right)$, expressed as two real-valued probabilities. Round each probability to four significant figures. Express the final answer as a row vector with the two probabilities in the order $\\left(P_{\\text{efficacy}}, P_{\\text{futility}}\\right)$.", "solution": "The objective is to compute the probabilities of stopping early for efficacy and for futility at the single planned interim analysis. These probabilities are denoted $P_{\\text{efficacy}}$ and $P_{\\text{futility}}$, respectively. The stopping rules are defined based on the value of the standardized $z$-statistic, $Z(t)$, at the information fraction $t=0.5$.\n\nThe problem states that under a fixed alternative hypothesis with a true standardized effect size $\\mu$, the monitoring statistic $Z(t)$ follows a normal distribution:\n$$Z(t) \\sim \\mathcal{N}(\\mu \\sqrt{t}, 1)$$\nThis is the canonical joint normal model for a group sequential design.\n\nWe are given the following values:\n- Information fraction for the interim analysis: $t = 0.5$\n- True standardized effect size (drift parameter): $\\mu = 1.5$\n- Efficacy stopping boundary: $a_1 = 2.342$\n- Futility stopping boundary: $b_1 = 0.2$\n\nFirst, we must determine the specific distribution of the test statistic $Z(0.5)$ at the interim look, under the specified true effect size $\\mu=1.5$. Substituting the given values into the general distributional form, we find the mean of the distribution:\n$$\\text{E}[Z(0.5)] = \\mu \\sqrt{t} = 1.5 \\times \\sqrt{0.5} = 1.5 \\times \\frac{1}{\\sqrt{2}} = \\frac{1.5}{\\sqrt{2}}$$\nNumerically, the mean is approximately $1.06066$. The variance is given as $1$.\nThus, the distribution of the statistic at the interim analysis is:\n$$Z(0.5) \\sim \\mathcal{N}\\left(1.5\\sqrt{0.5}, 1\\right)$$\n\nThe probability of stopping for efficacy, $P_{\\text{efficacy}}$, is the probability that the observed statistic $Z(0.5)$ is greater than or equal to the efficacy boundary $a_1$.\n$$P_{\\text{efficacy}} = P(Z(0.5) \\geq a_1)$$\nSubstituting the value for $a_1$:\n$$P_{\\text{efficacy}} = P(Z(0.5) \\geq 2.342)$$\n\nTo compute this probability, we standardize the random variable. Let $X = Z(0.5)$. We know $X \\sim \\mathcal{N}(\\nu, 1)$ where $\\nu = 1.5\\sqrt{0.5}$. Then the variable $W = X - \\nu$ follows a standard normal distribution, $W \\sim \\mathcal{N}(0, 1)$.\n$$P(X \\geq 2.342) = P(X - \\nu \\geq 2.342 - \\nu) = P(W \\geq 2.342 - 1.5\\sqrt{0.5})$$\nLet $\\Phi(\\cdot)$ denote the cumulative distribution function (CDF) of the standard normal distribution. Then $P(W \\geq z) = 1 - P(W  z) = 1 - \\Phi(z)$.\n$$P_{\\text{efficacy}} = 1 - \\Phi(2.342 - 1.5\\sqrt{0.5})$$\nWe now calculate the argument of the CDF:\n$$2.342 - 1.5\\sqrt{0.5} \\approx 2.342 - 1.060660 = 1.281340$$\nSo, $P_{\\text{efficacy}} = 1 - \\Phi(1.281340)$. Using standard normal probability tables or a computational tool, we find:\n$$\\Phi(1.281340) \\approx 0.899963$$\n$$P_{\\text{efficacy}} \\approx 1 - 0.899963 = 0.100037$$\nRounding to four significant figures, we get $P_{\\text{efficacy}} = 0.1000$.\n\nNext, we compute the probability of stopping for futility, $P_{\\text{futility}}$. This is the probability that the observed statistic $Z(0.5)$ is less than or equal to the futility boundary $b_1$.\n$$P_{\\text{futility}} = P(Z(0.5) \\leq b_1)$$\nSubstituting the value for $b_1$:\n$$P_{\\text{futility}} = P(Z(0.5) \\leq 0.2)$$\nAgain, we standardize the random variable using its known distribution $Z(0.5) \\sim \\mathcal{N}(1.5\\sqrt{0.5}, 1)$.\n$$P(Z(0.5) \\leq 0.2) = P(Z(0.5) - 1.5\\sqrt{0.5} \\leq 0.2 - 1.5\\sqrt{0.5})$$\nThis is equivalent to finding the value of the standard normal CDF at the specified point.\n$$P_{\\text{futility}} = \\Phi(0.2 - 1.5\\sqrt{0.5})$$\nWe calculate the argument of the CDF:\n$$0.2 - 1.5\\sqrt{0.5} \\approx 0.2 - 1.060660 = -0.860660$$\nSo, $P_{\\text{futility}} = \\Phi(-0.860660)$. Using standard normal probability tables or a computational tool, we find:\n$$P_{\\text{futility}} \\approx 0.194723$$\nRounding to four significant figures, we get $P_{\\text{futility}} = 0.1947$.\n\nThe problem states that the stopping rules are non-overlapping, which is confirmed by $a_1  b_1$. Therefore, the requested joint probability vector of early stopping is simply the vector containing the two separately calculated probabilities.\n\nThe resulting probability vector is $(P_{\\text{efficacy}}, P_{\\text{futility}})$, which, after rounding, is $(0.1000, 0.1947)$.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n0.1000  0.1947\n\\end{pmatrix}\n}\n$$", "id": "4918101"}, {"introduction": "The very act of monitoring a trial and making decisions based on accumulating data can introduce bias into the final statistical estimates if not handled correctly. This exercise [@problem_id:4918074] tackles this advanced topic by guiding you through the construction of an adjusted confidence interval that properly accounts for the sequential nature of the trial. By comparing the width of this adjusted interval to a \"naive\" one, you will see firsthand why specialized methods are essential for reporting accurate and reliable results from adaptive trials.", "problem": "A two-arm randomized clinical trial compares the mean outcome between a treatment and a control. Assume independent and identically distributed outcomes with known variance $\\sigma^{2} = 1$ per subject in each arm. Let the parameter of interest be the true mean difference $\\theta$ (treatment minus control). The trial is monitored with one interim analysis and one final analysis under a pre-specified stopping rule: a two-sided Pocock boundary with critical value $c_{1} = c_{2} = 2.41$ for total type I error $\\alpha = 0.05$.\n\nThe design uses equal sample sizes at both looks: $n_{1} = 100$ per arm at the interim and an additional $n_{2} = 100$ per arm at the final, for a total of $n_{1} + n_{2} = 200$ per arm if not stopped early. At the interim, the stage-$1$ mean difference estimate is $\\hat{\\theta}_{1} = 0.20$; in the second stage, based on the new data only, the stage-$2$ mean difference estimate is $\\hat{\\theta}_{2} = 0.05$. Assume stage-wise independence between the interim and the second-stage data.\n\nConsider the Inverse-Normal Combination Test (INCT) with weights $w_{1} = \\sqrt{\\frac{n_{1}}{n_{1} + n_{2}}}$ and $w_{2} = \\sqrt{\\frac{n_{2}}{n_{1} + n_{2}}}$ to combine the stage-wise standardized statistics. Under the parameter value $\\theta$, define the stage-wise standardized $z$-statistics\n$$\nz_{1}(\\theta) = \\frac{\\hat{\\theta}_{1} - \\theta}{\\mathrm{SE}_{1}}, \\quad z_{2}(\\theta) = \\frac{\\hat{\\theta}_{2} - \\theta}{\\mathrm{SE}_{2}},\n$$\nwhere $\\mathrm{SE}_{j}$ is the standard error of the stage-$j$ mean difference based on $n_{j}$ subjects per arm, and the INCT combination statistic\n$$\nC(\\theta) = w_{1}\\,z_{1}(\\theta) + w_{2}\\,z_{2}(\\theta).\n$$\nUnder the monitoring rule, the trial would have stopped early for efficacy at the interim if $|z_{1}(\\theta)| \\geq c_{1}$; otherwise it continues and would reject at the final if $|C(\\theta)| \\geq c_{2}$. A $(1-\\alpha)$ confidence interval for $\\theta$ that accounts for the stopping rule is obtained by inverting this two-stage procedure: it is the set of $\\theta$ values for which the observed path would not have led to rejection at either stage under that $\\theta$.\n\nUsing the given data and design:\n- Derive the adjusted two-sided $(1-\\alpha)$ confidence interval for $\\theta$ by inverting the INCT with the Pocock boundaries, and compute its width.\n- Derive the naive fixed-sample two-sided $(1-\\alpha)$ confidence interval for $\\theta$ that ignores interim monitoring, using the combined data from both stages as if there were no stopping rule, and compute its width.\n- Compute the ratio of the adjusted CI width to the naive CI width.\n\nExpress the final ratio as a single real number and round your answer to four significant figures. No units are required.", "solution": "First, we calculate the necessary statistics based on the provided data.\nThe variance of a mean difference estimate $\\hat{\\theta}_j$ based on $n_j$ subjects per arm is $\\text{Var}(\\hat{\\theta}_j) = \\frac{\\sigma^2}{n_j} + \\frac{\\sigma^2}{n_j} = \\frac{2\\sigma^2}{n_j}$.\nThe standard error for stage $j$ is $\\text{SE}_j = \\sqrt{\\frac{2\\sigma^2}{n_j}}$.\nGiven $n_1 = 100$, $n_2 = 100$, and $\\sigma^2=1$:\n$$\n\\text{SE}_1 = \\sqrt{\\frac{2(1)}{100}} = \\sqrt{0.02}\n$$\n$$\n\\text{SE}_2 = \\sqrt{\\frac{2(1)}{100}} = \\sqrt{0.02}\n$$\nThe INCT weights are:\n$$\nw_1 = \\sqrt{\\frac{n_1}{n_1+n_2}} = \\sqrt{\\frac{100}{100+100}} = \\sqrt{\\frac{1}{2}}\n$$\n$$\nw_2 = \\sqrt{\\frac{n_2}{n_1+n_2}} = \\sqrt{\\frac{100}{100+100}} = \\sqrt{\\frac{1}{2}}\n$$\nThe trial did not stop at the interim stage, as the observed statistic under the null hypothesis $\\theta=0$ is $|z_1(0)| = |\\hat{\\theta}_1/\\text{SE}_1| = |0.20/\\sqrt{0.02}| \\approx 1.414$, which is less than the critical value $c_1=2.41$.\n\n**Part 1: Adjusted Confidence Interval (CI)**\n\nThe adjusted $(1-\\alpha)$ confidence interval is the set of all values of $\\theta$ that are consistent with the observed data $(\\hat{\\theta}_1, \\hat{\\theta}_2)$ not leading to a rejection at either stage. This means finding $\\theta$ such that:\n1.  $|z_1(\\theta)|  c_1$\n2.  $|C(\\theta)|  c_2$\n\nThe first condition gives the interval $I_1$:\n$$\n\\left|\\frac{\\hat{\\theta}_1 - \\theta}{\\text{SE}_1}\\right|  c_1 \\implies \\hat{\\theta}_1 - c_1 \\text{SE}_1  \\theta  \\hat{\\theta}_1 + c_1 \\text{SE}_1\n$$\nUsing the given values:\n$c_1 \\text{SE}_1 = 2.41 \\sqrt{0.02} \\approx 2.41 \\times 0.14142 = 0.34082$.\n$I_1 = (0.20 - 0.34082, 0.20 + 0.34082) = (-0.14082, 0.54082)$.\n\nThe second condition involves the combination statistic $C(\\theta)$. The final estimate for $\\theta$ is the inverse-variance weighted average of the stage-wise estimates:\n$$\n\\hat{\\theta}_{final} = \\frac{n_1 \\hat{\\theta}_1 + n_2 \\hat{\\theta}_2}{n_1+n_2} = \\frac{100(0.20) + 100(0.05)}{100+100} = \\frac{20+5}{200} = \\frac{25}{200} = 0.125\n$$\nThe standard error of this final estimate is:\n$$\n\\text{SE}_{final} = \\sqrt{\\frac{2\\sigma^2}{n_1+n_2}} = \\sqrt{\\frac{2(1)}{200}} = \\sqrt{\\frac{1}{100}} = 0.1\n$$\nThe combination statistic $C(\\theta)$ can be expressed as $C(\\theta) = (\\hat{\\theta}_{final} - \\theta)/\\text{SE}_{final}$.\nThis gives the interval $I_2$:\n$$\n\\left|\\frac{\\hat{\\theta}_{final} - \\theta}{\\text{SE}_{final}}\\right|  c_2 \\implies \\hat{\\theta}_{final} - c_2 \\text{SE}_{final}  \\theta  \\hat{\\theta}_{final} + c_2 \\text{SE}_{final}\n$$\nUsing the calculated values:\n$c_2 \\text{SE}_{final} = 2.41 \\times 0.1 = 0.241$.\n$I_2 = (0.125 - 0.241, 0.125 + 0.241) = (-0.116, 0.366)$.\n\nThe adjusted confidence interval $CI_{adj}$ is the intersection of these two intervals:\n$$\nCI_{adj} = I_1 \\cap I_2 = (-0.14082, 0.54082) \\cap (-0.116, 0.366)\n$$\nThe intersection is $(\\max(-0.14082, -0.116), \\min(0.54082, 0.366)) = (-0.116, 0.366)$.\nThe width of the adjusted CI is:\n$$\nW_{adj} = 0.366 - (-0.116) = 0.482\n$$\n\n**Part 2: Naive Confidence Interval**\n\nThe naive CI ignores the sequential nature of the trial and is constructed as a standard fixed-sample CI using all the data.\nIt is centered at $\\hat{\\theta}_{final} = 0.125$ with standard error $\\text{SE}_{final} = 0.1$.\nFor a total type I error of $\\alpha = 0.05$, the two-sided critical value is $z_{1-\\alpha/2} = z_{0.975} \\approx 1.96$.\nThe naive CI is given by:\n$$\nCI_{naive} = \\hat{\\theta}_{final} \\pm z_{0.975} \\times \\text{SE}_{final}\n$$\n$$\nCI_{naive} = 0.125 \\pm 1.96 \\times 0.1 = 0.125 \\pm 0.196\n$$\n$$\nCI_{naive} = (0.125 - 0.196, 0.125 + 0.196) = (-0.071, 0.321)\n$$\nThe width of the naive CI is:\n$$\nW_{naive} = 2 \\times z_{0.975} \\times \\text{SE}_{final} = 2 \\times 1.96 \\times 0.1 = 0.392\n$$\n\n**Part 3: Ratio of Widths**\n\nThe ratio of the adjusted CI width to the naive CI width is:\n$$\nR = \\frac{W_{adj}}{W_{naive}} = \\frac{0.482}{0.392}\n$$\n$$\nR \\approx 1.2295918...\n$$\nRounding to four significant figures, the ratio is $1.230$.", "answer": "$$\n\\boxed{1.230}\n$$", "id": "4918074"}]}